NCT03645148View on ClinicalTrials.gov

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

November 1, 2020

Study Completion Date

April 1, 2021

Conditions
Pancreatic CancerPancreatic Carcinoma
Interventions
BIOLOGICAL

iNeo-Vac-P01

Neoantigen peptides

OTHER

GM-CSF

immune adjuvant

Trial Locations (1)

Unknown

Zhejiang Provincial People's Hospital, Hangzhou

All Listed Sponsors
collaborator

Hangzhou Neoantigen Therapeutics Co., Ltd.

INDUSTRY

lead

Zhejiang Provincial People's Hospital

OTHER

NCT03645148 - Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter